We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » PFIZER: DELAY OMNITROPE RULING UNTIL FOLLOW-ON BIOLOGICS MEETING
PFIZER: DELAY OMNITROPE RULING UNTIL FOLLOW-ON BIOLOGICS MEETING
August 16, 2004
Pfizer wants the FDA to delay its decision on a widely watched follow-on biologics application until after the agency holds a meeting next month on the scientific issues related to follow-on biologics and develops a draft guidance next year on how to approve versions of the complex proteins.